Skip to main content
VCbacked
Log inGet Started

Ansa Biotechnologies

Emeryville, United States

Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.

$45.2M raised
Oct 2025
Series B
BiotechnologyLife ScienceTherapeutics

Top Investors

RA Capital ManagementY CombinatorNational Science FoundationFifty YearsBlack Opal Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ansa Biotechnologies

How much funding has Ansa Biotechnologies raised?
Ansa Biotechnologies has raised $45.2M in total funding. The most recent round was Series B. The last funding was announced in October 2025.
Who are Ansa Biotechnologies's investors?
Ansa Biotechnologies's investors include RA Capital Management, Y Combinator, National Science Foundation, Fifty Years, Black Opal Ventures.
Where is Ansa Biotechnologies headquartered?
Ansa Biotechnologies is headquartered in Emeryville, United States.
What does Ansa Biotechnologies do?
Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.
What stage is Ansa Biotechnologies at?
Ansa Biotechnologies is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ansa Biotechnologies — Funding & Investors." VCBacked, October 1, 2025, https://www.vcbacked.co/company/ansa-biotechnologies. Accessed June 3, 2026.
APA
VCBacked. (2025). Ansa Biotechnologies — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/ansa-biotechnologies
Wikipedia (cite web)
{{cite web |title=Ansa Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/ansa-biotechnologies |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong